Online Webinar 2019 - Live Webinar Effective Change Control Programs
Topics/Call fo Papers
Overview
Regulatory agencies require pharmaceutical and medical device companies to have a systematic approach to managing all changes made to a facility, their product or a quality system. Given the fact that changes are inevitable, it is essential that companies have a compliant and effective change control program to ensure that no unnecessary or cGMP non-compliant changes occur. This Change Control training course will discuss regulatory expectations from the FDA, EU and ICH perspective, review all the required components of a thorough Change Control program; as well as, discuss the elements regarding successful management an effective Change Control system.
Session Highlights
Topic 1: Regulatory Guidance Review
FDA (CFR)
EU (EurdraLex)
ICH Q10
Topic 2: Review all Elements of a Change Control Record
Discuss the importance of utilizing Subject Matter Experts from multiple functional areas to ensure proper evaluation, approval and implementation of proposed changes.
Ensure changes do not negatively impact the business or established marketing authorization.
How to incorporate a Quality risk based approach to evaluating proposed changes
Ensure changes are implemented in a timely manner by effective use of the Change Control Review Board (CCRB) and Quality Metrics
Understand what steps should be taken post implementation to confirm the objectives were achieved
Why should you attend
At the completion of this course, attendees will be able to:
Interpret the requirements of the FDA, EU and ICH guidelines regarding compliant Change Control records.
Understand all the required components of a thorough Change Control record.
Understand all the elements of effective Change Control management:
How to develop a cross-functional team to ensure proper evaluation, approval and implementation of proposed changes.
Ensure changes do not negatively impact the business or established marketing authorization.
How to incorporate a Quality risk based approach to evaluating proposed changes
Ensure changes are implemented in a timely manner by effective use of the Change Control Review Board (CCRB) and Quality Metrics
Understand what steps should be taken post implementation to confirm the objectives were achieved
Who will benefit
Operations employees that participate in Manufacturing
Engineering
Validation
Quality Assurance and Regulatory Affairs as part of their job function – includes employees in the following departments:
Production
Engineering & Validation
Facilities / Maintenance
Quality Assurance
Regulatory Affairs
Speaker
Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.
Regulatory agencies require pharmaceutical and medical device companies to have a systematic approach to managing all changes made to a facility, their product or a quality system. Given the fact that changes are inevitable, it is essential that companies have a compliant and effective change control program to ensure that no unnecessary or cGMP non-compliant changes occur. This Change Control training course will discuss regulatory expectations from the FDA, EU and ICH perspective, review all the required components of a thorough Change Control program; as well as, discuss the elements regarding successful management an effective Change Control system.
Session Highlights
Topic 1: Regulatory Guidance Review
FDA (CFR)
EU (EurdraLex)
ICH Q10
Topic 2: Review all Elements of a Change Control Record
Discuss the importance of utilizing Subject Matter Experts from multiple functional areas to ensure proper evaluation, approval and implementation of proposed changes.
Ensure changes do not negatively impact the business or established marketing authorization.
How to incorporate a Quality risk based approach to evaluating proposed changes
Ensure changes are implemented in a timely manner by effective use of the Change Control Review Board (CCRB) and Quality Metrics
Understand what steps should be taken post implementation to confirm the objectives were achieved
Why should you attend
At the completion of this course, attendees will be able to:
Interpret the requirements of the FDA, EU and ICH guidelines regarding compliant Change Control records.
Understand all the required components of a thorough Change Control record.
Understand all the elements of effective Change Control management:
How to develop a cross-functional team to ensure proper evaluation, approval and implementation of proposed changes.
Ensure changes do not negatively impact the business or established marketing authorization.
How to incorporate a Quality risk based approach to evaluating proposed changes
Ensure changes are implemented in a timely manner by effective use of the Change Control Review Board (CCRB) and Quality Metrics
Understand what steps should be taken post implementation to confirm the objectives were achieved
Who will benefit
Operations employees that participate in Manufacturing
Engineering
Validation
Quality Assurance and Regulatory Affairs as part of their job function – includes employees in the following departments:
Production
Engineering & Validation
Facilities / Maintenance
Quality Assurance
Regulatory Affairs
Speaker
Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.
Other CFPs
- Controlling Human Error in the Manufacturing Floor
- Live Webinar FDA’s New Import Program for 2019 : Be Prepared and Be Compliant
- 2019 Live Webinar : Validation Essentials for Medical Device Manufacturers – IQ, OQ, PQ
- Live Webinar 90 minutes Biopharmaceutical Analytics: Regulations and Validation
- Root Cause Analysis for CAPA Investigations A Systematic Approach Live Webinar
Last modified: 2019-05-22 20:35:41